Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges

A comprehensive review of the literature on chronic lymphocytic leukemia (CLL) patients and recommendations regarding the evaluation and treatment of these patients was conducted. The overall prevalence of CLL and COVID-19 concurrence was found to be 0.6% (95%CI: 0.5% to 0.7%). Diagnostic interactio...

Descripción completa

Detalles Bibliográficos
Autores principales: Roosta, Yousef, Behzadi, Farhad, Askari, Elham, Raeisi, Mortaza, Danandeh Mehr, Amin, Nouri-Vaskeh, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962997/
https://www.ncbi.nlm.nih.gov/pubmed/33747763
http://dx.doi.org/10.1016/j.lrr.2021.100239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962997/
https://www.ncbi.nlm.nih.gov/pubmed/33747763
http://dx.doi.org/10.1016/j.lrr.2021.100239

Ejemplares similares